Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Revenue (2018 - 2025)

AVITA Medical filings provide 8 years of Revenue readings, the most recent being $92.0 million for Q4 2025.

  • On a quarterly basis, Revenue rose 409.75% to $92.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $146.0 million, a 129.04% increase, with the full-year FY2025 number at $70.9 million, up 10.93% from a year prior.
  • Revenue hit $92.0 million in Q4 2025 for AVITA Medical, up from $17.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $92.0 million in Q4 2025 to a low of $7.0 million in Q3 2021.
  • Median Revenue over the past 5 years was $12.7 million (2023), compared with a mean of $17.3 million.
  • Biggest five-year swings in Revenue: dropped 13.99% in 2022 and later soared 409.75% in 2025.
  • AVITA Medical's Revenue stood at $7.0 million in 2021, then skyrocketed by 34.69% to $9.5 million in 2022, then skyrocketed by 50.13% to $14.2 million in 2023, then rose by 27.14% to $18.0 million in 2024, then soared by 409.75% to $92.0 million in 2025.
  • The last three reported values for Revenue were $92.0 million (Q4 2025), $17.1 million (Q3 2025), and $18.4 million (Q2 2025) per Business Quant data.